1 Min Read
Oct 19 (Reuters) - AOBiome Therapeutics:
* AOBiome Therapeutics reports positive efficacy results from phase 2B clinical trial of ammonia oxidizing bacteria (AOB) for the treatment of acne vulgaris Source text for Eikon:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.